Publication date: December 2026 Source: EJC Paediatric Oncology, Volume 8 Author(s): Marlinde C. Schoonbeek, Vicky Amo-Addae, Mandy Koomen, Sarah Swaak, Eleonora J. Looze, Karin Langenberg, J. Christoph Lampert, Birgit Geoerger, Angelika Eggert, Gudrun Schleiermacher, Julia Schueler, Dennis Gürgen, Gilles Vassal, Sander van Hooff, Marlinde L. van den Boogaard, Jan J. Molenaar, Else Driehuis, Selma Eising
MicroOrganoSphere™ technology to advance drug screening in neuroblastoma precision medicine. // EJC Paediatric Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2772610X2600053X?dgcid=rss_sd_all
MicroOrganoSphere™ technology to advance drug screening in neuroblastoma precision medicine. EJC Paediatric Oncology. https://www.sciencedirect.com/science/article/pii/S2772610X2600053X?dgcid=rss_sd_all
“MicroOrganoSphere™ technology to advance drug screening in neuroblastoma precision medicine.” EJC Paediatric Oncology.
@article{article97843,
title = {MicroOrganoSphere™ technology to advance drug screening in neuroblastoma precision medicine},
journal = {EJC Paediatric Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2772610X2600053X?dgcid=rss_sd_all}
}